Your browser doesn't support javascript.
loading
Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel.
Khayrani, Apriliana Cahya; Mahmud, Hafizah; Oo, Aung Ko Ko; Zahra, Maram H; Oze, Miharu; Du, Juan; Alam, Md Jahangir; Afify, Said M; Quora, Hagar A Abu; Shigehiro, Tsukasa; Calle, Anna Sanchez; Okada, Nobuhiro; Seno, Akimasa; Fujita, Koki; Hamada, Hiroki; Seno, Yuhki; Mandai, Tadakatsu; Seno, Masaharu.
  • Khayrani AC; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. phrw1rm8@s.okayama-u.ac.jp.
  • Mahmud H; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. hfzhmhmd@gmail.com.
  • Oo AKK; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. kokooo.aung@gmail.com.
  • Zahra MH; Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan. maram@okayama-u.ac.jp.
  • Oze M; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. px934zug@s.okayama-u.ac.jp.
  • Du J; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. jahangir-geb@sust.edu.
  • Alam MJ; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. jahangir-geb@sust.edu.
  • Afify SM; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. jahangir-geb@sust.edu.
  • Quora HAA; Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan. pfgg90pn@s.okayama-u.ac.jp.
  • Shigehiro T; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-8530, Japan. Tsukasa.Shigehiro@roswellpark.org.
  • Calle AS; Center For Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Tsukasa.Shigehiro@roswellpark.org.
  • Okada N; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan. annasc.nit@gmail.com.
  • Seno A; Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan. aseno@okayama-u.ac.jp.
  • Fujita K; Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan. annasc.nit@gmail.com.
  • Hamada H; Okayama University Research Laboratory for Stem Cell Engineering in Detroit, Integrative Biosciences Center, Wayne State University, Detroit, MI 48202, USA. annasc.nit@gmail.com.
  • Seno Y; Ensuiko Sugar Refining Co., Ltd., Tokyo 103-0012, Japan. koki_fujita@pearlace.co.jp.
  • Mandai T; Faculty of Science, Okayama University of Science, Okayama 700-0005, Japan. hamada@dls.ous.ac.jp.
  • Seno M; Graduate School of Pharmaceutical Science, Tokushima University, Tokushima 770-8505, Japan. s20b028@sci.kusa.ac.jp.
Int J Mol Sci ; 20(5)2019 Feb 27.
Article en En | MEDLINE | ID: mdl-30818864

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Paclitaxel / Receptores de Hialuranos / Terapia Molecular Dirigida Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Paclitaxel / Receptores de Hialuranos / Terapia Molecular Dirigida Límite: Female / Humans Idioma: En Año: 2019 Tipo del documento: Article